These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10768966)

  • 1. Heterologous expression of Trypanosoma cruzi trans-sialidase in Leishmania major enhances virulence.
    Belen Carrillo M; Gao W; Herrera M; Alroy J; Moore JB; Beverley SM; Pereira MA
    Infect Immun; 2000 May; 68(5):2728-34. PubMed ID: 10768966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.
    Chuenkova M; Pereira ME
    J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma cruzi trans-sialidase: a potent and specific survival factor for human Schwann cells by means of phosphatidylinositol 3-kinase/Akt signaling.
    Chuenkova MV; Furnari FB; Cavenee WK; Pereira MA
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9936-41. PubMed ID: 11481434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of Active Trans-Sialidase Genes Impairs Egress from Mammalian Host Cells and Generates Highly Attenuated Trypanosoma cruzi Parasites.
    Burle-Caldas GA; Dos Santos NSA; de Castro JT; Mugge FLB; Grazielle-Silva V; Oliveira AER; Pereira MCA; Reis-Cunha JL; Dos Santos AC; Gomes DA; Bartholomeu DC; Moretti NS; Schenkman S; Gazzinelli RT; Teixeira SMR
    mBio; 2022 Feb; 13(1):e0347821. PubMed ID: 35073735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi trans-sialidase in complex with a neutralizing antibody: structure/function studies towards the rational design of inhibitors.
    Buschiazzo A; Muiá R; Larrieux N; Pitcovsky T; Mucci J; Campetella O
    PLoS Pathog; 2012 Jan; 8(1):e1002474. PubMed ID: 22241998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.
    Tribulatti MV; Mucci J; Van Rooijen N; Leguizamón MS; Campetella O
    Infect Immun; 2005 Jan; 73(1):201-7. PubMed ID: 15618155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex.
    Mucci J; Hidalgo A; Mocetti E; Argibay PF; Leguizamon MS; Campetella O
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3896-901. PubMed ID: 11891302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive phenotype of Trypanosoma cruzi restricted to a population expressing trans-sialidase.
    Pereira ME; Zhang K; Gong Y; Herrera EM; Ming M
    Infect Immun; 1996 Sep; 64(9):3884-92. PubMed ID: 8751943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion.
    Gao W; Wortis HH; Pereira MA
    Int Immunol; 2002 Mar; 14(3):299-308. PubMed ID: 11867566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parasite-derived trans-sialidase binds to heart tissue in Trypanosoma cruzi-infected animals.
    Alcântara-Neves NM; Ribeiro-dos-Santos R; Amor AL; Uemura H; Silva-Neto SJ; Eichinger D; Pontes-de-Carvalho L
    Microb Pathog; 2004 Nov; 37(5):273-8. PubMed ID: 15519048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of trypomastigote trans-sialidase in metacyclic forms of Trypanosoma cruzi increases parasite escape from its parasitophorous vacuole.
    Rubin-de-Celis SS; Uemura H; Yoshida N; Schenkman S
    Cell Microbiol; 2006 Dec; 8(12):1888-98. PubMed ID: 16824037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased cruzipain and gp85/trans-sialidase family protein expression contributes to loss of Trypanosoma cruzi trypomastigote virulence.
    San Francisco J; Barría I; Gutiérrez B; Neira I; Muñoz C; Sagua H; Araya JE; Andrade JC; Zailberger A; Catalán A; Remonsellez F; Vega JL; González J
    Microbes Infect; 2017 Jan; 19(1):55-61. PubMed ID: 27553285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies.
    Freire-de-Lima L; Fonseca LM; Oeltmann T; Mendonça-Previato L; Previato JO
    Glycobiology; 2015 Nov; 25(11):1142-9. PubMed ID: 26224786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal immunization with a L. lactis-derived trans-sialidase antigen plus c-di-AMP protects against acute oral T. cruzi infection.
    Pacini MF; González FB; Dinatale B; Bulfoni Balbi C; Villar SR; Farré C; Lupi G; Espariz M; Blancato VS; Magni C; Marcipar I; Pérez AR
    Vaccine; 2022 Apr; 40(15):2311-2323. PubMed ID: 35279330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.
    Fujimura AE; Kinoshita SS; Pereira-Chioccola VL; Rodrigues MM
    Infect Immun; 2001 Sep; 69(9):5477-86. PubMed ID: 11500420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-Sialidase rides the show.
    Campetella O; Buscaglia CA; Mucci J; Leguizamón MS
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165692. PubMed ID: 31972227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E).
    Erdmann H; Steeg C; Koch-Nolte F; Fleischer B; Jacobs T
    Cell Microbiol; 2009 Nov; 11(11):1600-11. PubMed ID: 19552697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Applicability of Neutralizing Antibodies to Trypanosoma cruzi Trans-sialidase.
    Leguizamón MS
    Methods Mol Biol; 2019; 1955():239-246. PubMed ID: 30868532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T rypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas' disease.
    Dc-Rubin SS; Schenkman S
    Cell Microbiol; 2012 Oct; 14(10):1522-30. PubMed ID: 22747789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.